Bile Reflux
7
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Associations Among Serum and Gastric Juice Bile Acid Profile, Bile Acid-microbiota Cross-talk in Stomach and the Development of Gastric Cancer
Connection Between Tongue Signs and Bile Reflux Analysed With Artificial Intelligence
Bile Reflux Gastropathy: Prevalence and Risk Factors After Therapeutic Biliary Interventions
Evaluation of Biliary Reflux After Mini-gastric Bypass With Using the Biliary Reflux Index
Omega Loop Gastric Bypass With And Without Anti-Reflux Sutures
Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux Disease
The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy